The
high blood level of low-density lipoprotein cholesterol
(LDL-C)
is a primary risk factor for cardiovascular disease. Plant sterols,
known as phytosterols (PSs), can reduce LDL-C in a range of 8–14%.
The extent of LDL-C reduction depends on its formulation. Encapsulation
into liposomes is one formulation strategy to enhance the efficiency
of PSs. PSs (campesterol, stigmasterol, and β-sitosterol) have
frequently been assessed alone or in combination for their LDL-C-lowering
ability. However, one naturally abundant PS, brassicasterol, has not
yet been tested for its efficacy. We have previously developed a novel
liposomal formulation containing the PS mixture present naturally
in canola that is composed of brassicasterol, campesterol, and β-sitosterol.
In this work, the efficacy of our novel liposomal PS formulation that
includes brassicasterol was assessed in a hamster model. Animals were
divided into five groups: (i) liposomal PS in orange juice, (ii) liposomal
PS in water, (iii) marketed PS in orange juice, (iv) control orange
juice, and (v) control water. The animals were fed a high-fat, cholesterol-supplemented
(0.5%) diet to induce hypercholesterolemia. The treatment was administered
orally once daily for 4 weeks. Fasting blood samples were collected
at baseline, week 2, and week 4. The extent of the reduction of total
cholesterol, LDL-C, high-density lipoprotein cholesterol (HDL-C),
and triglycerides was compared among the groups. Liposomal PSs in
both orange juice and water significantly reduced LDL-C compared to
their controls. Furthermore, the liposomal PS was as effective as
a marketed PS-containing product in reducing LDL-C. Liposomal PSs
in both orange juice and water showed similar efficacy in LDL-C reduction,
highlighting that these vehicles/food matrices do not affect the efficacy
of PSs. The liposomal formulation of a natural PS mixture extracted
from canola oil, with brassicasterol as a major component, exhibited
a significant LDL-C reduction in a hamster model.